Search Results

You searched for : EuropeanMedicinesAgency  

Pfizer and BioNTech to supply the European Union with 100 million additional doses of COVID vaccine

COMIRNATY will be produced in BioNTech’s and Pfizer’s manufacturing sites in Europe ...
Apr 20

Germany and Canada limits use of AstraZeneca vaccine

Germany restricts the vaccine for those over 60 while Canada restriction at 55 years and older...
Mar 31

Tessa Therapeutics receives PRIME designation from EMA for CD30 CAR-T Therapy

Tessa announced, EMA has granted PRiority MEdicines designation to the company's lead autologous CD30 CAR-T therapy for the treatment of relapsed or refractory ...
Jan 19

PFIZER’S XALKORI APPROVED BY USFDA FOR ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA IN CHILDREN AND YOUNG ADULTS

XALKORI is the first biomarker-driven therapy for relapsed or refractory ALCL in young people ...
Jan 15

WuXi Biologics receives GMP certification from Brazil's ANVISA

The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard...
Dec 28

EU approves Pfizer-BioNTech's corona vaccine for use in 27 nation grouping

EU mass vaccination programme to roll out soon...
Dec 22

Fortress Biotech announces US FDA has granted breakthrough therapy designation for CUTX-101

Fortress Biotech declares US FDA has granted breakthrough therapy designation for CUTX-101, Copper Histidinate, for the treatment of Menkes Disease ...
Dec 16

USFDA approves Roche’s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ...
Dec 15

CHMP recommends approval of Plavix with aspirin in adults for certain types of strokes

CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack ...
Dec 12

ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European ...
Dec 04

BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China

BNT162b2 is currently in Phase 3 clinical trials in the United States, Germany, Argentina, Brazil, South Africa, Turkey and other countries...
Nov 20

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

...
Nov 02

Janssen submits new drug application to U.S. FDA for treatment of schizophrenia in adults

...
Nov 02

AbbVie submits regulatory applications to US FDA and EMA for RINVOQ (upadacitinib) in atopic dermatitis

These submissions are an important step forward in the commitment to providing an additional treatment option ...
Oct 20

Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy

...
Oct 09

Pfizer announces FDA approval of oncology supportive care Biosimilar , NYVEPRIA

NYVEPRIA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia...
Jun 17

16 Matching result(s) found!

-Advertisements-




Trending Now

Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024
“Kusum Ka Biyaah” Indian Hindi film based on a true story releasing on 1st March 2024February 19, 2024
Introducing Moscow's Pioneering Initiative: An Open Dataset for AI-driven Brain Disease Detection"February 19, 2024
ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat DiscomfortFebruary 19, 2024
Section 43B of the Income Tax demystifiedFebruary 16, 2024
Nutricircle Introduces Health Supplements My45NutrientsTM to Enhance Overall Well-beingFebruary 16, 2024
YFLO organised a session “Design Your Story” to inspire young FICCI Ladies to design their own compelling storiesFebruary 15, 2024
149 experts call to find all TB to stop TBFebruary 15, 2024
ICPA Welcomes Global Leader In Periodontal Aesthetics - Prof Giovanni Zucchelli On His Inaugural Visit To IndiaFebruary 14, 2024
Fast Fashion and Sustainability are not friends and do not go well with each other: Namrata Joshipura, one of India’s most celebrated Fashion designers February 14, 2024
YFLO to organise a session Design Your StoryFebruary 14, 2024
Starkey Launches Genesis AI Hearing Aids in India, Pioneering a New Era in Hearing HealthFebruary 14, 2024
Indian Institute of Heritage and University of Birmingham announce strategic partnershipFebruary 14, 2024
Siddharth Anand’s Fighter emerges as the first hit of 2024February 13, 2024
India’s 26 years old youth’s Adventurous Atal Yatra to Celebrate Silver Jubilee of the Golden Quadrilateral beginsFebruary 13, 2024
Vitafoods India 2024 - Exploring Nutraceutical FrontiersFebruary 13, 2024